APA (7th ed.) Citation

Gluz, O., Xu, B., Nanda, R., Dasgupta, A., Kaushik, A., Verret, W., . . . Rugo, H. S. Efficacy of sacituzumab govitecan versus treatment of physician’s choice in previously treated HR+ and HER2− mBC: A meta-analysis of TROPiCS-02 and EVER-132-002 trials. SAGE Publishing.

Chicago Style (17th ed.) Citation

Gluz, Oleg, Binghe Xu, Rita Nanda, Anandaroop Dasgupta, Ankita Kaushik, Wendy Verret, Akanksha Sharma, Barinder Singh, and Hope S. Rugo. Efficacy of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Previously Treated HR+ and HER2− MBC: A Meta-analysis of TROPiCS-02 and EVER-132-002 Trials. SAGE Publishing.

MLA (9th ed.) Citation

Gluz, Oleg, et al. Efficacy of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Previously Treated HR+ and HER2− MBC: A Meta-analysis of TROPiCS-02 and EVER-132-002 Trials. SAGE Publishing.